Circle Pharma Names CID-165 as Second Oncology Candidate
17 Dec 2025 //
BUSINESSWIRE
Circle Pharma Reveals Cyclin D1 Program Preclinical Data
23 Oct 2025 //
BUSINESSWIRE
Circle Pharma to Present Cyclin D1 RxL Anti-Tumor Data at AACR
14 Oct 2025 //
BUSINESSWIRE

Market Place
Sourcing Support